Yamamoto et al., 2021 - Google Patents
Phosphorylated proteome analysis of a novel germline ABL1 mutation causing an autosomal dominant syndrome with ventricular septal defectYamamoto et al., 2021
View PDF- Document ID
- 14684956543113502779
- Author
- Yamamoto H
- Hayano S
- Okuno Y
- Onoda A
- Kato K
- Nagai N
- Fukasawa Y
- Saitoh S
- Takahashi Y
- Kato T
- Publication year
- Publication venue
- International Journal of Cardiology
External Links
Snippet
Background A gain-of-function mutation in germline ABL1 causes a syndrome including congenital heart defects. However, the molecular mechanisms of this syndrome remain unknown. In this study, we found a novel ABL1 mutation in a Japanese family with …
- 230000035772 mutation 0 title abstract description 44
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fischer | Conservation and divergence of the p53 gene regulatory network between mice and humans | |
Cohen et al. | An acetylation switch controls TDP-43 function and aggregation propensity | |
Sorio et al. | Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis | |
Zhang et al. | Comparative transcriptomic and proteomic analyses provide insights into the key genes involved in high-altitude adaptation in the Tibetan pig | |
Schuch et al. | FARS1‐related disorders caused by bi‐allelic mutations in cytosolic phenylalanyl‐tRNA synthetase genes: look beyond the lungs! | |
EP2550371A1 (en) | Protein and gene biomarkers for rejection of organ transplants | |
Perrault et al. | IFT81, encoding an IFT-B core protein, as a very rare cause of a ciliopathy phenotype | |
Yuan et al. | MEF2C loss-of-function mutation associated with familial dilated cardiomyopathy | |
Tian et al. | Renal regional proteomes in young Dahl salt-sensitive rats | |
Chen et al. | An MTF1 binding site disrupted by a homozygous variant in the promoter of ATP7B likely causes Wilson Disease | |
Blue et al. | Whole genome sequencing in transposition of the great arteries and associations with clinically relevant heart, brain and laterality genes | |
Andrade et al. | Adipose tissue epigenetic profile in obesity-related dysglycemia-a systematic review | |
Loureiro et al. | A recurrent SHANK3 frameshift variant in Autism Spectrum Disorder | |
Woon et al. | Pediatric Dilated Cardiomyopathy‐Associated LRRC10 (Leucine‐Rich Repeat–Containing 10) Variant Reveals LRRC10 as an Auxiliary Subunit of Cardiac L‐Type Ca2+ Channels | |
Chaithra et al. | High-risk genes involved in common septal defects of congenital heart disease | |
Mendonça Belmont et al. | Single nucleotide polymorphisms at+ 191 and+ 292 of Galectin-3 Gene (LGALS3) related to lower GAL-3 serum levels are associated with frequent respiratory tract infection and vaso-occlusive crisis in children with sickle cell anemia | |
Yamamoto et al. | Phosphorylated proteome analysis of a novel germline ABL1 mutation causing an autosomal dominant syndrome with ventricular septal defect | |
Quast et al. | Functional coding variants in SLC6A15, a possible risk gene for major depression | |
Tremmel et al. | Hepatic expression of the Na+-taurocholate cotransporting polypeptide is independent from genetic variation | |
Bae Sohn et al. | Clinical and genetic spectrum of 18 unrelated Korean patients with Sotos syndrome: frequent 5q35 microdeletion and identification of four novel NSD1 mutations | |
Baca et al. | Loss of function of the zinc finger homeobox 4 gene, ZFHX4, underlies a neurodevelopmental disorder | |
Mascibroda et al. | INTS13 mutations causing a developmental ciliopathy disrupt integrator complex assembly | |
Zhao et al. | Clinical features of CNOT3-associated neurodevelopmental disorder in three Chinese patients | |
Kim et al. | Proteogenomic study beyond chromosome 9: new insight into expressed variant proteome and transcriptome in human lung adenocarcinoma tissues | |
Hendig et al. | New ABCC6 gene mutations in German pseudoxanthoma elasticum patients |